We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer. Galera Therapeutics Inc is a biopharmaceutical company focused on developing therapeutics that have the potential to transform radiotherapy in cancer.
MALVERN, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing a pipeline of novel, proprietary...
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have...
MALVERN, Pa., March 28, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0192 | 10.8597285068 | 0.1768 | 0.233 | 0.1531 | 671742 | 0.18202108 | CS |
4 | 0.0085 | 4.53333333333 | 0.1875 | 0.233 | 0.1531 | 801085 | 0.18638057 | CS |
12 | -0.023 | -10.502283105 | 0.219 | 0.29 | 0.1314 | 2136971 | 0.20079772 | CS |
26 | 0.0515 | 35.6401384083 | 0.1445 | 0.29 | 0.115 | 1819706 | 0.19188088 | CS |
52 | -3.184 | -94.201183432 | 3.38 | 3.59 | 0.0853 | 2655213 | 0.43789718 | CS |
156 | -7.544 | -97.4677002584 | 7.74 | 10.79 | 0.0853 | 2085224 | 1.88994169 | CS |
260 | -12.304 | -98.432 | 12.5 | 19.5 | 0.0853 | 1423823 | 2.14834447 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions